I'm LongbridgeAI, I can summarize articles.Revenue: As of FY2026 Q2, the actual value is USD 49.19 M.
EPS: As of FY2026 Q2, the actual value is USD 0.1.
EBIT: As of FY2026 Q2, the actual value is USD 19.08 M.
Second Quarter 2026 Financial Highlights
- Total Revenues: $49 million, an increase of 13% year-over-year .
- Net Income Attributable to SBC Medical: $11 million, an increase of 335% year-over-year .
- Net Income Margin: 22%, an increase of 16 percentage points year-over-year .
- Adjusted EBITDA: $20 million, an increase of 32% year-over-year .
- Adjusted EBITDA Margin: 41%, an increase of 6 percentage points year-over-year .
Operational Metrics (Q2 2026)
- Number of Locations: Increased by 34 year-over-year to 287 as of June 2026 .
- Last-Twelve-Month Number of Visits: Reached 6.9 million, up 10% year-over-year .
- Average Spend Per Visit: $287, up 9% year-over-year .
First Half 2026 Financial Highlights
- Total Revenues: $92 million, an increase of 2% year-over-year .
- Net Income Attributable to SBC Medical: $22 million, a decrease of -8% year-over-year .
- Net Income Margin: 24%, a decrease of -2 percentage points year-over-year .
- Adjusted EBITDA: $38 million, a decrease of -4% year-over-year .
- Adjusted EBITDA Margin: 42%, a decrease of -2 percentage points year-over-year .
- ROE (Annualized): 17%, a decrease of -5 percentage points year-over-year .
Balance Sheet (as of June 30, 2026)
- Cash and Cash Equivalents: $184,311,213, compared to $163,773,838 as of December 31, 2025 .
- Total Assets: $406,659,022, compared to $380,447,946 as of December 31, 2025 .
- Total Liabilities: $126,743,880, compared to $117,143,240 as of December 31, 2025 .
- Total Stockholders’ Equity: $279,915,142, compared to $263,304,706 as of December 31, 2025 .
Cash Flow (Six Months Ended June 30, 2026)
- Net Cash Provided by Operating Activities: $31,741,248, compared to - $6,411,168 for the six months ended June 30, 2025 .
- Net Cash Provided by Investing Activities: $37,206, compared to $15,397,998 for the six months ended June 30, 2025 .
- Net Cash Used in Financing Activities: - $3,803,472, compared to $6,901,719 for the six months ended June 30, 2025 .
Outlook / Guidance
SBC Medical Group Holdings expects to increase service fees by approximately $15 million annually through fee revisions for call center services and expanded support for Rize Clinic and Gorilla Clinic . The company plans to deepen its multi-brand strategy in aesthetic dermatology, expand its non-aesthetic business, and accelerate global growth through collaboration with OrangeTwist and ASEAN expansion . SBC Medical Group Holdings is also preparing to enter the Longevity market and will continue disciplined investment towards its next growth phase, supported by $184 million in cash and cash equivalents .